Human Dobrava hantavirus infections in Estonia

Lancet

Volumn 352, Issue 9125, 1998, Pages 369-

  Lundkvist, Åke ^a   Vasilenko, Vera ^b   Golovljova, Irina ^b   Plyusnin, Alexander ^b   Vaheri, Antti ^b  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY;

ANTIBODY TITER; ARTICLE; ESTONIA; HANTAVIRUS; HEMORRHAGIC FEVER; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SEROEPIDEMIOLOGY; VIRUS INFECTION;

EID: 17344388246     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)60467-9     Document Type: Article

References (5)

1. 1 Plyusnin A, Vapalahti O, Vaheri A. Hantaviruses: genome structure, expression and evolution. J Gen Virol 1996; 77: 2677-87.
2. 2 Avsic-Zupanc T, Toney A, Anderson K, et al. Genetic and antigenic properties of Dobrava virus: a unique member of the Hantavirus genus, family Bunyaviridae. J Gen Virol 1995; 76: 2801-08.
3. 3 Lundkvist Å, Hukic M, Hörling J, et al. Puumala and Dobrava viruses cause haemorrhagic fever with renal syndrome in Bosnia-Herzegovina: evidence of highly cross-neutralising antibody responses in early patient sera. J Med Virol 1997; 53: 51-59.
4. 4 Lundkvist Å, Apekina N, Myasnikov Y, Vapalahti O, Vaheri A, Plyusnin A. Dobrava hantavirus outbreak in Russia. Lancet 1997; 350: 781-82.
5. 5 Plyusnin A, Vapalahti O, Vasilenko V, Henttonen H, Vaheri A. Dobrava hantaviruse in Estonia: does the virus exist throughout Europe? Lancet 1997; 349: 1369-70.